{
  "id": 3793944,
  "title": "New testing of black-market peptides reveals high-dose risk",
  "url": "https://urgent.news/2026/08/27/new-testing-of-black-market-peptides-reveals-high-dose-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T18:47:30.000Z",
  "source": {
    "name": "ABC News AU",
    "slug": "abc-news-au",
    "url": "https://www.abc.net.au/news/2026-08-28/black-market-peptides-dangerous-doses/107059092"
  },
  "original_language": "en",
  "account": "A chemical testing lab has begun analyzing unapproved peptides, following a surge in demand for the products on social media. A popular counterfeit weight-loss peptide known as retatrutide was tested, and two out of three vials contained a significantly higher concentration than stated on the label. Regulatory authorities have cautioned against injecting unapproved peptides due to their lack of human safety testing. Analytical chemist Grace Hamann, whose work now primarily consists of testing peptides, said that the demand for such testing has increased exponentially. Leeder Analytical, where Ms. Hamann works, had to develop a new method to accurately test these substances. The lab recently tested three vials of counterfeit retatrutide, supplied by ABC and the University of Queensland, and found that while one vial contained less than indicated, the other two had much higher concentrations. Only one of the tested samples matched its label claim. The most common request for testing is for purity, but the lab's findings reveal that 30% of samples had higher concentrations, while another 30% had lower concentrations. One vial contained no retatrutide at all. The lab's results suggest that inaccurate dosing could be a significant risk, even more so than underdosing, which has been more prevalent in steroid testing. Liver transplant specialist Marie Sinclair has treated patients experiencing liver failure after taking black-market peptides labeled as retatrutide, emphasizing the danger of unregulated products. While purity testing can confirm the presence of the peptide, it does not guarantee the absence of other contaminants or toxins. Australia's medicines regulator, the Therapeutic Goods Administration, stated that counterfeit peptides have not undergone clinical trials or safety testing, making them unsafe for injection.",
  "summary": "A chemical testing lab begins testing unapproved peptides as demand for the products booms on social media.",
  "key_points": [
    "Two out of three counterfeit retatrutide vials had higher concentrations than labeled.",
    "30% of tested samples had higher concentrations, while another 30% had lower concentrations.",
    "Liver failure cases linked to black-market peptides highlight danger of unregulated products."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}